Deep dive · NasdaqCM: RGC
Regencell Bioscience Holdings Limited stock analysis
Everything behind the call on Regencell Bioscience Holdings Limited. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Global tape
No overseas listings — RGC trades on its home exchange only.
The bottom linestart hereAs of 2026-09-25
Chart pattern
Between the averages
The 50-day sits below the 200-day
50-day $5.73 · +7.6%
200-day $19.42 · -68.2%
200-day $19.42 · -68.2%
Earnings
In 32 days
28 Oct 2026
cohort P(beat) 61% · n=139,854
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
1 critical
5 checks run, 2 clear
beta 1.44 · vol 83% ann.
worst drawdown -91%
worst drawdown -91%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does119 chars
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
NasdaqCM · USDSpecialty & Generic Pharma
$6.170.00 · 0.00%CLOSED · vol 51.1K
52-week range↑ 37% off low · ↓ 91.1% off high
$4.51now $6.17$69.00
Quote Sep 25, 2026 · 4:00 PM ET
Tape 2026-09-25
Factors 2026-09-25
Tape 2026-09-25
Factors 2026-09-25
01Ratios · Jul 7, 2026
Survival & solvency
and 2 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Distance to default (Merton)
7.1σCOMFORTABLE
How many standard deviations of asset value sit between the company and its debt. Above 4σ is comfortable.
Balance sheetJul 7, 2026
1-year default probabilityEDF-CALIBRATED
0.12%
Calibrated against how often companies at this distance actually defaulted, rather than assuming a normal distribution.
Piotroski F-scoreCRITICAL
F 3/8
Piotroski F-score 3 of 8. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Your ownership stake
Share-count growth vs peersLOW DILUTION
25th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Diluted vs basic share gapTHIN OVERHANG
0.00%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE C
62 / 100
1 critical · 1 watch · 2 clear of 4 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressCLEARZ 32299.03Altman-Z in the Safe · fundamentals
Earnings manipulationNAn/aBeneish-M not available · fundamentals
LeverageCLEARLTD/E 0.00long-term debt 0.00× equity · fundamentals
Profitability qualityCRITICALF 3/8Piotroski F-score 3 of 8 · fundamentals
Filing forensicsWATCH2 flags2 filing red flags on the latest 10-K · forensic
5 checks, 2 clear and 1 watch and 1 critical. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 26, 2026FAIR · 52/100
Business quality
The quality blocks below render whatever the filings support; anything absent says so in place.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
52 / 100FAIR
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 26, 2026
Asset growth vs peersIN LINE
9th pctile
The balance sheet grew -32% on the year. Fast asset growth is usually a ramp; occasionally it is the start of an inventory problem.
Growth & relative strength
Trailing return by period
1 month+11.8%
3 months-0.3%
6 months-76.0%
Year to date-70.0%
1 year-59.2%
12-1 momentumEX LAST MONTH
-62.3%
Return over the last year excluding the most recent month — the standard momentum factor, which drops the short-term reversal.
Relative-strength rankBOTTOM 46%
46 / 100
Where this name's 3-month return against the S&P 500 ranks across the market — a quarter's standing, not the year's.
Around earnings
P(beat next quarter)COHORT BASE RATE
61%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Typical earnings moveData unavailableRealized move magnitudes are not published for this name yet — no measured print on file.
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Consensus biasVALIDATED
Persistent
insufficient surprise history
Next reportIN 32 DAYS
28 Oct 2026
Reports amc · revenue 0.00
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.
No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 26, 2026
Uptrend · leans bullish
HorizonHigherMedianObservations
10d47%0.0%1,132,432
21d47%-0.1%531,932
63d48%-0.7%170,248
slope +0.10 over 40 bars
Tweezer top · leans bearish
HorizonHigherMedianObservations
10d46%0.0%324,295
21d47%0.0%152,024
63d50%0.0%48,500
matching highs
03
Price & timing
Price $6.17, RSI 53.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Trend
Mixed2 OF 3 AVERAGES
50-day $5.73 · 200-day $19.42. Price above both is the structural definition of an uptrend.
The setup right now
Price · 504 sessions2024-09-23 → 2026-09-25
price50-day200-day
How to read this
Up 0.00% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
Momentum (RSI-14)COOL
53
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
Typical day (ATR-14)±6.9%
$0.43
The average true range — how far this stock moves on an ordinary day. It sets the scale a stop has to clear.
MACDABOVE SIGNAL
+0.06
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Bollinger position62% OF RANGE
Mid band
Where price sits inside its own volatility band. The edges are where a move is stretched, not where it reverses.
20-day VWAPPRICE BELOW
$6.24
The volume-weighted average of the last month. Price above it means recent buyers are, on average, in profit.
Chandelier exitBROKEN
$6.37
A volatility-based trailing stop, set a few average ranges below the recent high.
28 Oct 2026 · in 32 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 14 Jul; companies confirm about three weeks ahead, so it can still move.
2026-09-29 · in 3 daysJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Pullback riskoverstretch read
In line1.20× segment rate · n=12,184
Historically, mid names in this tape state saw a ≥10% pullback within 63 trading days in 95% of cases (n=12,184).
Overstretchvs the 20-day mean
0.5σ
How many standard deviations price sits from its 20-day mean. Beyond 2σ is genuinely stretched; inside it is ordinary.
Bottom zoneif it breaks down
$5 – $62 supports
Where prior demand appeared: S1 at $6.07, Pivot low at $5.48.
Slide scorefalling-knife check
0 / 100Neutral
A composite of consecutive down days, gap risk and volume expansion. Low means any decline is orderly.
Signal
The odds lean, the stretch qualifies it.
Not enough fundamental coverage to score this name's red-flag cohort — no 12-month odds shown.
Valuation
Data unavailableNo parsed earnings or cash flows are on file, so no multiple can be computed. A pre-profit company has nothing to divide the price into.
Price horizon & timingSep 25, 2026
Entryzone of pivot low + S1
$6.14In zone
Where the composer's entry sits, on its own stated basis.
Target52-week high
$69.00$69–$69
A zone, not a price. It is where the composer expects supply, not a forecast.
StopTucked under the entry zone
$5.16risk $0.98/sh
The level that says the setup is wrong, on the basis named beside it.
Risk / rewardtarget vs stop
64.13:1
Reward against risk on the composer's own levels.
Measure from a price$
To the 50-day
-7.1%
short-term trend line · $5.73
To the 200-day
+214.7%
primary trend line · $19.42
To the composer's target
+1,018.3%
52-week high · set Sep 25, 2026 · $69.00
To the composer's stop
-16.4%
Tucked under the entry zone · set Sep 25, 2026 · $5.16
To the 52-week high
+1,018.3%
highest print of the past year · $69.00
To the 52-week low
-26.9%
lowest print of the past year · $4.51
A typical day (ATR)
$5.74 – $6.60
±$0.43 average true range
Type any price to re-measure every distance from it. Each row is a level this page already states somewhere else, so nothing here is a new number — and none of it is a recommendation to trade at that price.
Signal
The levels line up.
Entry $6.14 · stop $5.16 · target $69.00, a 64.13:1 ratio. The composer flagged: elevated distress, far target.
Gamma map
Data unavailableThis name has no listed options chain, so there is no dealer gamma to map. Regime, flip level, walls and the implied move all need a chain to exist.
Options tape
Data unavailableNo options chain is connected for this ticker. Max pain, the put/call ratio, the implied move and the open-interest ladder all need the chain feed.
0413F quarterly · Form 4 dailyNET SIGNAL -2
Ownership & flow
Institutions hold 0%, short interest is 1.45% of float.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
-2BALANCED · 30d
0 bull / 1 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Quality / valueTTM · CONTEXT
-2
weak Piotroski F-score (3/8)
Signal
0 bull / 1 bear factors
Independent factors scored and netted to -2 over 30d, a balanced reading. 1 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.
Cross-category read
Data unavailableFewer independent evidence families are ready than the engine's minimum, so there is nothing to check for agreement. A cross-category read over two categories is not a read.
Wall Street
Data unavailableNo sell-side firm publishes research on this name. There is no consensus rating, no price target and no estimate revisions to weigh — for a company this size that is the norm rather than a gap in our data.
Who owns it13F quarterly · Form 4 daily
Institutional ownershipRETAIL-HEAVY
0.3%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
88.4%
The share held by the people running the company.
Short interest (float)LIGHT
1.45%
Falling — shares short changed -19.1% over 30 days. There is no short base to squeeze here.
Free float11% OF SHARES
55.41M
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)49th PCTILE
$1.89M/day
Average dollars traded per day, and where that ranks cross-sectionally. Thin liquidity is a cost you pay on the way out, not just on the way in.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
The story · news & sentimentRolling window
Why it moved todayNONE
0.00%
RGC was little changed +0.00% since the last close — no notable catalyst, and the move itself was modest.
CongressSTOCK Act · 30–45d lag
Signal
Net selling.
1 of 6 disclosures are buys and 5 are sales. Lawmakers disclose on a 30–45 day legal lag, so this describes what was done weeks ago, not what is being done now.
050 graded callsHIGH VOLATILITY
Risk & track record
Beta 1.44, 83% annual volatility, a -91% worst drawdown, and 2 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
A very bad day (EVT)
−15.9%1-IN-200 DAY
Fitted to the tail of the return distribution rather than assuming a bell curve. Size the position so a day like this is survivable.
What it does to a portfolio5-year window
Beyond the tail (ES)1-IN-1,000 DAY
−28.9%
The average loss on a 1-in-1,000 day or worse — deeper in the tail than the 1-in-200 figure above and further than the measured history reaches, so it reads as the scale of a crash, not a forecast of one.
Tail understatementNEAR-NORMAL
0.9×
The tail runs close to what a normal curve would predict, so volatility is a reasonable proxy for risk here — which is not true of every name.
Max drawdownIT CAN HALVE
-91.0%
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
Beta (vs the market)LOW FIT
1.44
The market explains about 1.6% of its daily moves, so this beta says little about how it tracks the index — most of its movement is its own.
Annualized volatilityELEVATED
83%
How far it swings over a year, from its own realized returns.
Tactical phaseNIGHTLY READ
Neutral
Selling pressure0
Buying pressure51
Overheat26
State: neutral — No dominant short-horizon pressure in the tape.
What votes againstNightly
MedQuality / valueweak Piotroski F-score (3/8)TTM · -2
Signal
1 of 9 factors vote against.
Ranked by the size of each factor's own point contribution to the net signal — these are the model's stated reasons, not a written bear case. Each one is scored from the source named beside it.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Suggested position capmax defensible size
1.6%tail cap binds
max defensible size 1.6% - tail binds
Avoid score6-month distress
47.8%6.4× its cohort · thinly-traded small-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this thinly-traded small-caps segment: 7.5%. This name reads 6.4× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
MedPosition size, not conviction, is the binding constrainthalf-Kelly 12.4% · tail cap 1.6% · category cap 54.6%. The tail cap binds, so 1.6% is the number (n=109,931). We show which one binds rather than the friendliest.Sizing
MedLottery-ticket behaviourIts best 21-day return sits at 14.7% against a 9.6% cohort 90th-percentile threshold — above the line where forward returns have historically turned negative.Behaviour
LowCash runwayNot scored for this name.Not scored
LowPost-earnings driftDrift odds at full strength (+3.21% / 63-day spread reference from measured post-earnings drift).Timing
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
2 of 8 surfaces clear.
8 surfaces checked, 2 clear. The binding constraint is position size — the tail cap is the one that binds. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You can't sit through -91%
That is this name's deepest measured fall, on 83% annualized volatility. A drawdown of that size is normal here, not exceptional.
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
You're already heavy in this market
A 1.44 beta means you would be stacking the same bet rather than spreading it.
You'd be buying into earnings
A report lands in 32 days.
You'd size it like a core holding
The binding cap is 1.6% of a portfolio. Above that the tail stops being survivable.
Our track record0 resolved
Track recordBUILDING IN THE OPEN
3 logged
3 calls logged on this name, 0 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on RGCTHIS NAME
3
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 0.
0610-K disclosed linksSPECIALTY & GENERIC PHARMA
The wider context
5 mapped peers, 1 connection.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
+3,252.4% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
JHPCYPeer$11.500.00%
GDERFPeer$203.60-0.91%
TAKPeer$18.86+1.45%
GALDYPeer$39.45+0.31%
TKPHFPeer$37.000.00%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
1 of 4 backward windows are positive.
Look-back returns describe what happened, not what is likely. They are here to set the scale a future move would be measured on.
Macro driversRolling window
Next macro catalystIN 3 DAYS
Job Openings (JOLTS)
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 21, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day +1.8% · A week later +61.3% · Two weeks later +92.7% · Rose on 66 of 170 report days
Across the last 170 Initial jobless claims reports since Jun 8, 2023, RGC moved +1.8% on average on the day and was 92.7% higher two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 3 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +2.5% · A week later +5.0% · Two weeks later +41.0% · Rose on 17 of 39 report days
Across the last 39 Core PCE (the Fed's gauge) reports since Jun 28, 2023, RGC moved +2.5% on average on the day and was 41.0% higher two weeks later. The S&P 500 moved +0.2% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
On the day +0.2% · A week later +7.8% · Two weeks later +270.2% · Rose on 16 of 39 report days
Across the last 39 FOMC decision reports since Jul 1, 2023, RGC moved +0.2% on average on the day and was 270.2% higher two weeks later. The S&P 500 moved -0.1% on those days.
On the day -2.8% · A week later +4.7% · Two weeks later +6.7% · Rose on 8 of 39 report days
Across the last 39 Housing starts reports since Jun 20, 2023, RGC moved -2.8% on average on the day and was 6.7% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day +371.3% · A week later +152.9% · Two weeks later +96.8% · Rose on 14 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, RGC moved +371.3% on average on the day and was 96.8% higher two weeks later. The S&P 500 moved +0.1% on those days.
PCE inflation is due in 3 days.
PCE inflationLittle effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +2.5% · A week later +5.0% · Two weeks later +41.0% · Rose on 17 of 39 report days
Across the last 39 PCE inflation reports since Jun 28, 2023, RGC moved +2.5% on average on the day and was 41.0% higher two weeks later. The S&P 500 moved +0.2% on those days.
Producer prices (PPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.9% · A week later +224.7% · Two weeks later +106.9% · Rose on 14 of 39 report days
Across the last 39 Producer prices (PPI) reports since Jun 12, 2023, RGC moved -0.9% on average on the day and was 106.9% higher two weeks later. The S&P 500 moved +0.3% on those days.
On the day +371.3% · A week later +152.9% · Two weeks later +96.8% · Rose on 14 of 39 report days
Across the last 39 Retail sales reports since Jun 15, 2023, RGC moved +371.3% on average on the day and was 96.8% higher two weeks later. The S&P 500 moved +0.1% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections1 link · none confirmed
Direct connections · 1 edge
CompanyRelationSessionProvenance
JNJ · Competitorcompetitor+0.20%Rumored · manual
0 of 1 edge is named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Suppliers, customers & competitors
Named competitors
JNJCompetitorcompetitor
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.